TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

18 hedge funds and large institutions have $932K invested in Theriva Biologics in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.87M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$120K
2
+$54K
3
+$19.1K

Top Sellers

1
-$256K
2
-$64K
3
-$21.4K
4
Citadel Advisors
Citadel Advisors
Florida
-$17K
5
TSS
Two Sigma Securities
New York
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$497K
2
$240K
3
$54K
4
$33K
5
$30K
6
$24K
7
$21K
8
$10K
9
$9K
10
$6K
11
$6K
12
$2K
13
$1
14
–
15
–
16
–
17
–
18
–